{"id":"https://openalex.org/W1590600306","doi":null,"title":"[Impact of treatment with acetylcholinesterase inhibitors, valproic acid and antipsychotics on aggressive behaviour in Alzheimer's type dementia].","display_name":"[Impact of treatment with acetylcholinesterase inhibitors, valproic acid and antipsychotics on aggressive behaviour in Alzheimer's type dementia].","publication_year":2012,"publication_date":"2012-05-01","ids":{"openalex":"https://openalex.org/W1590600306","mag":"1590600306","pmid":"https://pubmed.ncbi.nlm.nih.gov/23045890"},"language":"pl","primary_location":{"id":"pmid:23045890","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23045890","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria polska","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016884848","display_name":"Leszek Bidzan","orcid":"https://orcid.org/0000-0002-4373-5459","observed_orcids":["https://orcid.org/0000-0002-4373-5459"]},"institutions":[{"id":"https://openalex.org/I75124487","display_name":"Gda\u0144sk Medical University","ror":"https://ror.org/019sbgd69","country_code":"PL","type":"education","lineage":["https://openalex.org/I75124487"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Leszek Bidzan","raw_affiliation_strings":["Klinika Psychiatrii Rozwojowej, Zaburze\u0144 Psychotycznych i Wieku Podesz\u0142ego Gda\u0144ski Uniwersytet Medyczny"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinika Psychiatrii Rozwojowej, Zaburze\u0144 Psychotycznych i Wieku Podesz\u0142ego Gda\u0144ski Uniwersytet Medyczny","institution_ids":["https://openalex.org/I75124487"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089804925","display_name":"Jakub Grabowski","orcid":"https://orcid.org/0000-0002-0638-4565","observed_orcids":["https://orcid.org/0000-0002-0638-4565","https://orcid.org/0009-0002-8024-7160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jakub Grabowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009031372","display_name":"Beata Dutczak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beata Dutczak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027359112","display_name":"Mariola Bidzan","orcid":"https://orcid.org/0000-0003-0224-1994","observed_orcids":["https://orcid.org/0000-0003-0224-1994"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariola Bidzan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1972,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.76086792,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"46","issue":"3","first_page":"361","last_page":"72"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9700000286102295},{"id":"https://openalex.org/keywords/aggression","display_name":"aggression","score":0.9330000281333923},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9549999833106995},{"id":"https://openalex.org/keywords/dementia-progression","display_name":"dementia progression","score":0.7570000290870667},{"id":"https://openalex.org/keywords/nursing-home-residents","display_name":"nursing home residents","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cohen-mansfield-agitation-inventory","display_name":"Cohen-Mansfield Agitation Inventory","score":0.9100000262260437},{"id":"https://openalex.org/keywords/adas-cog","display_name":"ADAS-Cog","score":0.6949999928474426},{"id":"https://openalex.org/keywords/behavioural-symptoms","display_name":"behavioural symptoms","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.7042944431304932},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6140773892402649},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5220220685005188},{"id":"https://openalex.org/C2776153860","wikidata":"https://www.wikidata.org/wiki/Q394129","display_name":"Psychomotor agitation","level":2,"score":0.5020730495452881},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4692639708518982},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4629640579223633},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.42684951424598694},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.42631250619888306},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4259251356124878},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.42505836486816406},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.19589990377426147},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.17147469520568848}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000374","descriptor_name":"Aggression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007175","descriptor_name":"Impulsive Behavior","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007175","descriptor_name":"Impulsive Behavior","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011044","descriptor_name":"Poland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018678","descriptor_name":"Cholinergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:23045890","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23045890","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria polska","raw_type":"Comparative Study"},{"id":"mag:1590600306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23045890","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2028769786","https://openalex.org/W3006205584","https://openalex.org/W2158019941","https://openalex.org/W2047055581","https://openalex.org/W2169539286","https://openalex.org/W7125395828","https://openalex.org/W2060787282","https://openalex.org/W2336354982","https://openalex.org/W1992109356","https://openalex.org/W6997496509"],"abstract_inverted_index":{"UNLABELLED:":[0],"Aggressive":[1,99],"and":[2,60,90,108,122,194,208,218,231,240,290],"impulsive":[3,195],"behaviour":[4,100,196,273],"are":[5],"common":[6],"in":[7,87,97,177,197,250,274],"Alzheimer's":[8,83,144,278],"dementia.":[9],"Therapy":[10],"of":[11,24,32,35,44,52,74,81,111,126,161,192,260,277,287],"these":[12],"disorders":[13],"is":[14],"an":[15],"important":[16],"but":[17,242],"difficult":[18],"practical":[19],"question.":[20],"AIM:":[21],"The":[22,65,151,172,202],"purpose":[23],"this":[25,133,243],"study":[26,66],"was":[27,67,101,116,154,175,188,262],"to":[28,148,199,281],"determine":[29],"the":[30,42,50,109,149,159,182,205,211,251,275,285],"effect":[31],"pharmacological":[33],"treatment":[34,53,130],"aggressive":[36,193,272],"behaviour,":[37],"while":[38,249],"taking":[39],"into":[40,138],"account":[41],"dynamics":[43],"disease":[45,84,145],"progression":[46,259],"during":[47,132],"observation.":[48,150],"In":[49,181],"assessment":[51],"acetylcholinesterase":[54],"inhibitors":[55,266],"(IAChE),":[56],"valproic":[57,288],"acid":[58,289],"(VA),":[59],"antipsychotics":[61,255],"were":[62,146,223],"considered.":[63],"METHOD:":[64],"based":[68],"on":[69,271],"a":[70,79,189,236,256],"two-year":[71],"naturalistic":[72],"observation":[73,127],"nursing":[75],"homes'":[76],"residents":[77],"with":[78,143,185,228,254,284],"diagnosis":[80],"possible":[82],"(NINCDS/ADRDA":[85],"criteria)":[86],"its":[88],"mild":[89],"moderate":[91],"stage":[92],"(at":[93],"least":[94],"12":[95],"points":[96,168],"MMSE).":[98],"measured":[102],"by":[103,113,164],"Cohen-Mansfield":[104],"Agitation":[105],"Inventory":[106],"(CMAI),":[107],"severity":[110],"dementia":[112,261],"ADAS--Cog.":[114],"Examination":[115],"performed":[117],"twice:":[118],"at":[119],"baseline":[120],"(0)":[121,209],"after":[123],"two":[124],"years":[125],"(2).":[128],"All":[129],"administered":[131],"time":[134],"has":[135,244],"been":[136],"taken":[137],"account.":[139],"71":[140],"people":[141],"diagnosed":[142],"enrolled":[147],"average":[152],"age":[153],"77.10":[155],"(SD":[156,169],"=":[157,166,170],"8.39),":[158],"level":[160],"cognitive":[162],"impairment":[163],"ADAS--Cog":[165],"20.40":[167],"5.24).":[171],"second":[173],"examination":[174,206],"conducted":[176],"43":[178],"individuals.":[179],"RESULTS:":[180],"group":[183,252],"treated":[184,227,253],"IAChE":[186],"there":[187],"lesser":[190],"increase":[191],"comparison":[198],"other":[200],"persons.":[201],"differences":[203],"between":[204],"(2)":[207],"for":[210,225],"CMAI":[212],"global":[213],"scale":[214],"were,":[215],"respectively,":[216],"2.76":[217],"9.09":[219],"points.":[220],"Similar":[221],"results":[222],"obtained":[224],"subjects":[226],"VA":[229],"(1.0":[230],"8.65).":[232],"Antipsychotic":[233],"drugs":[234],"revealed":[235],"similar":[237,280],"correlation":[238],"(3.0":[239],"8.65),":[241],"not":[245],"proven":[246],"statistically":[247],"relevant,":[248],"significantly":[257],"greater":[258],"observed.":[263],"CONCLUSION:":[264],"Acetylcholinesterase":[265],"may":[267],"have":[268],"beneficial":[269],"effects":[270],"course":[276],"Disease,":[279],"that":[282],"seen":[283],"use":[286],"antipsychotics.":[291]},"counts_by_year":[{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}